BCAL Diagnostics Limited
Save
48.42M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Diagnostics & Research
Industry
BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from extracellular vesicles from a patient's plasma or blood sample to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
Similar securities
Based on sector and market capitalization
Report issue